2021
Surveillance of Candidemia in Connecticut: An Epidemiological Comparison Between Two Periods
Gleason-Vergados J, Banach D, Clogher P, Meek J. Surveillance of Candidemia in Connecticut: An Epidemiological Comparison Between Two Periods. Antimicrobial Stewardship & Healthcare Epidemiology 2021, 1: s79-s80. PMCID: PMC9551423, DOI: 10.1017/ash.2021.156.Peer-Reviewed Original ResearchEmerging Infections ProgramEpidemiology of candidemiaCentral venous cathetersCommunity-onset infectionsVenous cathetersBlood culturesConnecticut residentsCDC's Emerging Infections ProgramCommon bloodstream infectionState-wide surveillanceExtended hospital stayIntravenous drug useAttributable mortality rateLength of stayPositive blood culturesCase report formsHigh treatment costsCandidemia managementCandidemia episodesHospital stayRecent surgeryPatient demographicsHospitalized patientsSignificant morbidityBloodstream infections
2020
A Statewide Assessment of Antifungal Stewardship Activities in Acute-Care Hospitals in Connecticut
Bromberg R, Leung V, Maloney M, Paranandi A, Banach D. A Statewide Assessment of Antifungal Stewardship Activities in Acute-Care Hospitals in Connecticut. Infection Control And Hospital Epidemiology 2020, 41: s105-s105. DOI: 10.1017/ice.2020.609.Peer-Reviewed Original ResearchAcute care hospitalsInfectious disease consultationCandida bloodstream isolatesDisease consultationAntifungal susceptibility testingAntifungal therapyBloodstream isolatesConnecticut hospitalsCandidemia treatmentSusceptibility testingInstitutional guidelinesAntibiotic stewardship principlesCandida bloodstream infectionsDays of therapyEmpiric antifungal therapyInfectious disease physiciansInvasive fungal infectionsCDC core elementsAntifungal expenditureAntifungal utilizationOral conversionDisease physiciansHospitalized patientsProspective auditBloodstream infections